Patient characteristics at baseline (n = 391). Values are mean (SD) unless otherwise specified.
| Characteristics | Multidisciplinary, n = 197* | Usual Care, n = 194* |
|---|---|---|
| Demographics | ||
| Age, yrs | 60.98 (8.2) | 61.47 (7.5) |
| Female, n (%) | 170 (86) | 168 (87) |
| BMI | 25.53 (4.5) | 25.77 (5.4) |
| SJC, 66 joints | 6.0 (7.9) | 7.3 (8.7) |
| TJC, 66 joints | 8.2 (8.8) | 9.9 (10.1) |
| Analgesics, daily | ||
| Paracetamol, n (%) | 34 (17) | 34 (18) |
| NSAID, n (%) | 35 (18) | 23 (12) |
| Pain and functioning | ||
| Pain, NRS | 5.39 (2.0) | 5.23 (2.1) |
| Fatigue, NRS | 4.24 (2.9) | 4.11 (2.8) |
| Stiffness, NRS | 5.11 (2.2) | 5.30 (2.5) |
| AUSCAN total | 4.65 (1.8) | 4.71 (1.9) |
| AUSCAN pain | 4.78 (1.8) | 4.79 (1.9) |
| AUSCAN stiffness | 4.63 (2.4) | 4.64 (2.2) |
| AUSCAN physical | 4.75 (2.0) | 4.9 (2.2) |
| WOMAC sum | 11.09 (5.5) | 11.69 (5.5) |
| WOMAC pain | 3.53 (2.0) | 3.97 (2.0) |
| WOMAC stiffness | 4.45 (2.1) | 4.43 (2.1) |
| WOMAC physical | 3.29 (2.0) | 3.62 (1.9) |
| ASES pain | 56.86 (17.9) | 57.33 (19.0) |
| ASES symptoms | 67.54 (16.9) | 69.27 (16.7) |
| HSCL-25 | 1.55 (0.5) | 1.54 (0.4) |
| HRQOL | ||
| SF-36 PCS | 31.3 (5.0) | 30.8 (4.7) |
| SF-36 MCS | 49.2 (5.6) | 49.4 (5.8) |
| EQ-5D | 0.64 (0.2) | 0.62 (0.3) |
Mixed model analyses.
↵* No significant differences between the 2 groups at baseline p > 0.05.
BMI: body mass index; SJC: swollen joint count; TJC: tender joint count; NSAID: nonsteroidal antiinflammatory drugs; NRS: numeric rating scale (11-point, range 0–10); AUSCAN: Australian/Canadian Hand Osteoarthritis Index; WOMAC: Western Ontario and McMaster Universities Osteoarthritis Index; ASES: Arthritis Self-Efficacy Scale; HSCL-25: Symptom Checklist 25; HRQOL: health-related quality of life; SF-36: Medical Outcomes Study Short Form-36; PCS: physical component summary; MCS: mental component summary.